Literature DB >> 1551060

Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.

R J Zaino1, S Ward, G Delgado, B Bundy, H Gore, G Fetter, P Ganjei, E Frauenhoffer.   

Abstract

Disagreement persists about the superiority of Reagan and Ng's method over that of Broders' for the histologic grading of squamous carcinoma of the cervix. Uncertainty about the predictive value and reproducibility of any of the grading methods prompted a comparison of factors previously suggested as indicating the biologic behavior for cervical squamous carcinoma. One hundred ninety-five women, who were enrolled in a Gynecologic Oncology Group treatment protocol of Stage IB squamous carcinoma of the cervix and underwent radical hysterectomy with pelvic and paraaortic node sampling, formed the study population. The tumors were graded first by participating institutional pathologists, with submitted slides subjected to an independent review by two pathologists (R.J.Z. and S.W.). The histologic parameters examined included the presence and amount of keratinization, nuclear pleomorphism, mitotic rate, gestalt grading, pattern of invasion at the stromal interface, and inflammatory cell infiltrate. The depth of invasion and presence or absence of vascular invasion also were assessed. The probability of pelvic lymph node metastasis and the progression-free interval were determined for each parameter. Surprisingly, none of the grading methods was effective in predicting nodal spread or progression-free interval. However, an increasing depth of invasion strongly correlated with nodal spread and a diminished progression-free interval (P less than 0.0001). Vascular invasion was less effective in these predictions (0.05 less than P less than 0.10). Both measurements were reasonable reproducible. It was concluded that histologic grading of surgically treated cervical carcinoma is not useful but that the depth of invasion and vascular invasion are important predictors of behavior that should be reported routinely.

Entities:  

Mesh:

Year:  1992        PMID: 1551060     DOI: 10.1002/1097-0142(19920401)69:7<1750::aid-cncr2820690717>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

Review 1.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

2.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

3.  What is your diagnosis?

Authors:  Cemil Yaman; Dietmar Haas; Radec Chvatal; Peter Oppelt
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

4.  Unusual Metastasis from Carcinoma Cervix.

Authors:  Virendra Bhandari; Mehlam Kausar; Ayush Naik; Manika Batra
Journal:  J Obstet Gynaecol India       Date:  2015-05-09

5.  Splenic Metastasis from Cancer of Uterine Cervix-a Rare Case.

Authors:  Jagannath Dixit; Noor Mohammed; Preethi Shetty
Journal:  Indian J Surg Oncol       Date:  2016-10-18

6.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

7.  Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.

Authors:  Djin Lai; Qian Ding; Julia Bodson; Echo L Warner; Deanna Kepka
Journal:  Public Health Nurs       Date:  2015-08-31       Impact factor: 1.462

8.  Value of pelvic examination and imaging modality for the evaluation of tumor size in cervical cancer.

Authors:  Yoo-Kyung Lee; Seung-Su Han; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

9.  Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.

Authors:  T P Thamboo; A Wee
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

10.  Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.

Authors:  Tong Shu; Dan Zhao; Bin Li; Yating Wang; Shuanghuan Liu; Pingping Li; Jing Zuo; Ping Bai; Rong Zhang; Lingying Wu
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.